| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Halozyme Therapeutics, Inc. (HALO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 36 sells. HALO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 777.8K | $53.29M | - | |
| Dir | 77.8K | $5.33M | - | |
| Dir | 43.7K | $2.99M | -1,625 | |
| Dir | 36.6K | $2.51M | - | |
| Dir | 23.7K | $1.62M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Connaughton Bernadette49 | Director | Sell | 2,000 | $75.24 | $150,481.00 | -2.2% | -9.7% | - | |
| Sep 22, 2025 | Labrosse Nicole60 | SVP, Chief Financial Officer | Sell | 2,227 | $77.95 | $173,584.49 | -4.8% | -12.9% | - | |
| Sep 10, 2025 | Labrosse Nicole60 | SVP, Chief Financial Officer | Sale+OE | 20,000 | $75.71 | $1,514,267.12 | -24.4% | -18.4% | - | |
| Sep 4, 2025 | Torley Helen61 | President And CEO | Sale+OE | 60,000 | $74.08 | $4,444,626.29 | -1.0% | -11.9% | - | |
| Sep 2, 2025 | Connaughton Bernadette49 | Director | Sell | 4,000 | $73.68 | $294,736.24 | -2.7% | -7.1% | - | |
| Aug 13, 2025 | Torley Helen61 | President And CEO | Sale+OE | 60,000 | $63.62 | $3,817,388.61 | -1.3% | +7.7% | - | |
| Jul 10, 2025 | Torley Helen61 | President And CEO | Sale+OE | 60,000 | $56.46 | $3,387,517.46 | -1.3% | +13.1% | - | |
| Jun 24, 2025 | Torley Helen61 | President And CEO | Sale+OE | 60,000 | $53.09 | $3,185,279.82 | -2.0% | +45.2% | - | |
| Apr 28, 2025 | Henderson Jeffrey William65 | Director | Sell | 4,497 | $60.37 | $271,467.09 | -7.3% | -4.7% | - | |
| Apr 1, 2025 | Henderson Jeffrey William65 | Director | Sell | 503 | $64.05 | $32,217.15 | -1.5% | -15.9% | +5.7% |